Full-Time

Quality Control Specialist II

Separation Sciences

Posted on 8/8/2024

Beam Therapeutics

Beam Therapeutics

501-1,000 employees

Develops precision genetic medicines using base editing

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Master’s degree with 8+ years of relevant experience or bachelor’s with 10+ years of experience.
  • Experience of executing analytical method transfer, qualification, and validation for mRNA and LNP products.
  • Extensive experience with several of the following analytical techniques is required: HPLC (IPRP, SEC, IEX), capillary gel electrophoresis, fluorescence-based RNA quantitation. Experience with qPCR, DNA and RNA extraction, ELISA, western blotting, UV spectrophotometry, DLS, MALS, mass spectrometry, and compendial testing will be a plus.
  • Experience using data analysis software including JMP and PLA software.
  • Knowledge of ICH/USP guidelines.
  • Proven track record of functional and potency assay technical transfer, qualification, and validation in a GMP laboratory.
  • Ability to critically think though experimental challenges and troubleshoot.
  • Team player with excellent oral and written communication skills.
  • Independently motivated, detail-oriented, and excellent problem-solving abilities.
  • Domestic and international travel may be required to external CTLs and other Beam sites.
Responsibilities
  • Optimize, technical transfer, qualification, and validation of separations and biophysical methods for mRNA and LNP products.
  • Execution of assays utilizing various analytical techniques such as (IPRP, SEC, IEX), capillary gel electrophoresis, fluorescence-based RNA quantitation. Experience with qPCR, DNA and RNA extraction, ELISA, western blotting, UV spectrophotometry, DLS, MALS, mass spectrometry, and compendial testing will be a plus.
  • Author and review SOPs and technical reports.
  • Acting as an SME resource to external partners.
  • Work with cross-functional groups including Research & Development, Analytical Development, and Process Development teams to participate in various aspects of method development, transfer, process and product characterization, comparability, and investigations.
  • Analyze, track, and trend data to monitor analytical assays and ensure consistency in assay performance.

Beam Therapeutics develops precision genetic medicines using a technique called base editing, which allows for precise modifications to the genetic code to potentially correct mutations that lead to serious diseases. Their primary focus is on treating genetic disorders, such as sickle cell disease, with the aim of providing lifelong cures instead of temporary solutions. The company invests significantly in research and development to create new therapies and generates revenue through partnerships, licensing agreements, and future commercialization of their treatments. Beam Therapeutics distinguishes itself from competitors by emphasizing a values-driven approach, a strong team of experts, and a commitment to rigorous scientific development, all aimed at achieving lasting health solutions for patients.

Company Stage

IPO

Total Funding

$215.9M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Base editing technology is gaining traction as a precise genetic correction method.
  • The $250 million deal with Eli Lilly boosts Beam's financial and strategic position.
  • Christi Shaw's appointment to the board brings valuable biotech leadership.

What critics are saying

  • Competition from CRISPR Therapeutics could impact Beam's market share.
  • Recent restructuring and layoffs may lead to operational challenges.
  • New CFO transition might pose financial management challenges.

What makes Beam Therapeutics unique

  • Beam Therapeutics uses base editing, a precise genetic correction method.
  • The company focuses on lifelong cures for genetic disorders like sickle cell disease.
  • Beam's strategic partnerships, like with Eli Lilly, enhance its market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

INACTIVE